ATE542896T1 - Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung - Google Patents

Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung

Info

Publication number
ATE542896T1
ATE542896T1 AT05809074T AT05809074T ATE542896T1 AT E542896 T1 ATE542896 T1 AT E542896T1 AT 05809074 T AT05809074 T AT 05809074T AT 05809074 T AT05809074 T AT 05809074T AT E542896 T1 ATE542896 T1 AT E542896T1
Authority
AT
Austria
Prior art keywords
dpp
protein hydrolyzate
protein hydrolysate
inhibiting peptides
enriched
Prior art date
Application number
AT05809074T
Other languages
English (en)
Inventor
Jan-Willem Pieter Boots
Original Assignee
Campina Nederland Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Campina Nederland Holding Bv filed Critical Campina Nederland Holding Bv
Application granted granted Critical
Publication of ATE542896T1 publication Critical patent/ATE542896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/548—Vegetable protein
    • A23V2250/5488—Soybean protein
AT05809074T 2004-12-23 2005-11-30 Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung ATE542896T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04078502 2004-12-23
PCT/NL2005/050056 WO2006068480A2 (en) 2004-12-23 2005-11-30 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use

Publications (1)

Publication Number Publication Date
ATE542896T1 true ATE542896T1 (de) 2012-02-15

Family

ID=36602170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05809074T ATE542896T1 (de) 2004-12-23 2005-11-30 Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung

Country Status (9)

Country Link
US (2) US8273710B2 (de)
EP (1) EP1831361B1 (de)
JP (1) JP5068174B2 (de)
KR (1) KR101331777B1 (de)
AT (1) ATE542896T1 (de)
DK (1) DK1831361T3 (de)
ES (1) ES2381118T3 (de)
TW (1) TWI421089B (de)
WO (1) WO2006068480A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1831361B1 (de) 2004-12-23 2012-01-25 Campina Nederland Holding B.V. Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung
EP1907412B1 (de) * 2005-06-30 2012-04-11 Campina Nederland Holding B.V. Das angiotensin-converting enzyme inhibierende peptide
JP2009517464A (ja) 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー．ブイ． グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
EP1840133A1 (de) * 2006-03-29 2007-10-03 Global Biotech Development Corp. Ltd. Neue immunomodulierende Oligopeptide
WO2007123200A1 (ja) * 2006-04-21 2007-11-01 Meiji Seika Kaisha, Ltd. ペプチドを有効成分として含有する組成物
WO2007125946A1 (ja) * 2006-04-28 2007-11-08 Snow Brand Milk Products Co., Ltd. ペプチド
JP2008189637A (ja) * 2007-02-08 2008-08-21 Snow Brand Milk Prod Co Ltd 自己免疫疾患予防剤
GB2451858A (en) * 2007-08-15 2009-02-18 Sergiy Konovchuk Methods of reducing body fat and treating obesity
CA2699055A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009128713A1 (en) * 2008-04-14 2009-10-22 Newtricious B.V. Egg protein hydrolysates
DE102008062136B4 (de) * 2008-12-16 2012-05-03 Kamamed Ug Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch
US20100210564A1 (en) * 2009-02-02 2010-08-19 Kyoto University Drug or food containing a peptide
JP5735734B2 (ja) * 2009-04-16 2015-06-17 雪印メグミルク株式会社 脂質代謝改善剤
JP2011084485A (ja) * 2009-10-13 2011-04-28 Snow Brand Milk Prod Co Ltd 脂肪蓄積抑制剤
AU2011221270A1 (en) * 2010-02-24 2012-09-13 Morinaga Milk Industry Co.,Ltd. Therapeutic agent for eating disorders
CN103068392A (zh) * 2010-05-12 2013-04-24 Mapi医药公司 苯甲酸阿格列汀的多晶形物
CN103108957B (zh) * 2010-08-24 2015-07-01 武汉九生堂生物工程有限公司 全蛋蛋白肽及其制备方法和应用
JP5832049B2 (ja) * 2012-03-09 2015-12-16 森永乳業株式会社 ジペプチジルペプチダーゼ−ｉｖ阻害剤
WO2013133032A1 (ja) * 2012-03-09 2013-09-12 森永乳業株式会社 ジペプチジルペプチダーゼ－ｉｖ阻害剤
WO2014060495A1 (en) * 2012-10-19 2014-04-24 Dsm Ip Assets B.V. Process for the production of an infant formula
CN103232526B (zh) * 2012-12-12 2015-06-24 上海交通大学 一种生物活性多肽lplp及其制备和应用
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) * 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) * 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
MY165122A (en) 2013-06-12 2018-02-28 Maruha Nichiro Corp Dipeptidyl peptidase-iv (dppiv) inhibitory peptide compound, composition containing the same, and production method for the same
CN103483418B (zh) * 2013-09-12 2015-04-01 陈尚武 一种dpp-ⅳ抑制多肽及其应用
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP5872725B1 (ja) * 2015-02-26 2016-03-01 ヤマキ株式会社 鰹節由来のジペプチジルペプチダーゼｉｖ阻害組成物
JP2017031105A (ja) * 2015-08-03 2017-02-09 森永乳業株式会社 食後血糖値の上昇抑制を促進させる剤
CN105341949B (zh) * 2015-10-09 2018-03-27 滨州万嘉生物科技有限公司 一种具有降血糖功能的鱼肉蛋白肽及其制备方法与应用
US11129404B2 (en) 2015-12-28 2021-09-28 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
WO2018159546A1 (ja) * 2017-03-03 2018-09-07 森永乳業株式会社 Ｇｌｐ－１分泌促進剤及び組成物
US11912788B2 (en) 2017-03-16 2024-02-27 Microsintesis Inc. Probiotic molecules for reducing pathogen virulence
CN110621689B (zh) * 2017-03-16 2024-04-16 微合成有限公司 涉及益生菌分子的组合物和方法
CN108314705B (zh) * 2018-01-26 2020-07-14 海普诺凯营养品有限公司 具有dpp-iv抑制功能的羊乳清蛋白肽、其制备方法及其应用
CN108935912B (zh) * 2018-06-21 2021-04-23 中国农业大学 一种具有dpp-ⅳ抑制和抗疲劳功能的鱼肉蛋白肽及其制备方法
JP7068942B2 (ja) * 2018-06-25 2022-05-17 サンスター株式会社 トリペプチド含有組成物
WO2021083958A1 (en) * 2019-10-29 2021-05-06 Specialites Pet Food Novel peptides inducing satiety
CN114621320A (zh) * 2020-12-14 2022-06-14 清华大学 一种可用于减缓glp-1酶解的短肽及其组合物
JPWO2022186290A1 (de) * 2021-03-02 2022-09-09
CN113035291B (zh) * 2021-04-08 2022-04-05 广东药科大学 计算机辅助药物设计dpp-iv抑制肽的方法、dpp-iv抑制肽及其应用
CN113480605A (zh) * 2021-07-27 2021-10-08 中国海洋大学 一种牦牛乳酪蛋白dpp-iv抑制肽及其筛选方法
CN114686551B (zh) * 2022-03-16 2023-08-08 江南大学 一种豌豆蛋白源dpp-iv抑制肽及其筛选方法
CN114836491B (zh) * 2022-05-30 2023-03-14 广州恒雅生物化工有限公司 一种抗老亮肤的肌肽制备方法及其在化妆品的应用
WO2024038888A1 (ja) * 2022-08-19 2024-02-22 森永乳業株式会社 組成物
CN115252759A (zh) * 2022-08-24 2022-11-01 四川大学华西第二医院 酸奶衍生多肽在制备延缓端粒缩短药物及抗衰老药物中的应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681586A (en) 1989-03-23 1997-10-28 Gordon; Arthur L. Enzyme-modified soy and soy/casein combination healing compositions
JP3119674B2 (ja) 1991-02-15 2000-12-25 日本合成化学工業株式会社 新規ペプチド、その製造法及び用途
DE4211878C2 (de) 1992-04-09 1995-04-20 Ralf Dr Med Kluge Mittel zur Behandlung der Multiplen Sklerose
WO1994011689A1 (en) * 1992-11-19 1994-05-26 Yu Tom Yen Shing Paper sheet coating apparatus with gas streams drying
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
JP3665663B2 (ja) * 1994-08-02 2005-06-29 カルピス株式会社 血圧降下剤及びその製造法
WO1998002165A1 (en) 1996-07-17 1998-01-22 Nutracorp Scientific, Inc. Appetite suppression
DE19828114A1 (de) * 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
CA2296311A1 (en) * 1999-01-28 2000-07-28 Universite Laval Enzymatic hydrolysate of milk proteins
EP1034704A1 (de) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nahrungszusammensetzung insbesondere für die spezifische gastrointestinale Reifung in frühgeborenen Säugetieren
AU5382200A (en) * 1999-06-15 2001-01-02 University Health Network Muc1 ligands
US20040152745A1 (en) * 1999-11-12 2004-08-05 Guilford Pharmaceuticals, Inc. Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
WO2002013850A1 (en) * 2000-08-17 2002-02-21 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
EP1201137B1 (de) 2000-10-24 2006-06-07 Campina Melkunie B.V. Peptiden reich an Cystein und/oder Glycin
CN100506981C (zh) 2000-12-07 2009-07-01 Dsmip资产有限公司 富含具有羧基末端脯氨酸残基的肽的蛋白质水解产物
AU2002302385B2 (en) * 2001-03-09 2005-10-06 Unilever Plc Fermented milk product
JP2002284668A (ja) 2001-03-26 2002-10-03 Cosmo Products Kk クスミの予防・治療剤
FR2825004B1 (fr) 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
CA2419888A1 (en) 2001-06-27 2003-01-09 Probiodrug Ag Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis
WO2003035051A2 (en) * 2001-10-19 2003-05-01 Inhale Therapeutic Systems, Inc. The use of proton sequestering agents in drug formulations
US20030165574A1 (en) 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
WO2003093498A1 (en) * 2002-04-29 2003-11-13 The Ohio State University Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic
DE60227922D1 (de) 2002-05-27 2008-09-11 Nestec Sa Säurelösliche Proteine aus Casein-Micellen
AU2003236689A1 (en) * 2002-06-04 2003-12-19 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
GB0213612D0 (en) 2002-06-13 2002-07-24 Novartis Nutrition Ag Organic compounds
WO2004002241A1 (en) 2002-07-01 2004-01-08 Unilever N.V. Satiety inducing composition
JP4719465B2 (ja) 2002-09-04 2011-07-06 ディーエスエム アイピー アセッツ ビー．ブイ． インスリン感受性増強剤およびペプチド画分を含む栄養補給用および治療用組成物
WO2004024177A1 (en) 2002-09-16 2004-03-25 Quest International Services B.V. Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
ATE469645T1 (de) * 2002-10-23 2010-06-15 Bristol Myers Squibb Co Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
EP1422293A1 (de) 2002-11-25 2004-05-26 F. Hoffmann-La Roche Ag Kristallstruktur der Dipeptidylpeptidase iV
US20070015269A1 (en) * 2002-11-25 2007-01-18 Michael Hennig Crystals of DPP-IV
DE60333868D1 (de) 2003-02-07 2010-09-30 Campina Bv Verwendung von tryptophanreichen peptiden aus molkenproteinhydrolysate zur behandlung von übergewicht und fettleibigkeit
GB0310593D0 (en) * 2003-05-08 2003-06-11 Leuven K U Res & Dev Peptidic prodrugs
EA200601575A1 (ru) 2004-03-01 2007-06-29 Пептера Фармасьютикалс Лтд. Казеиновые пептиды и их терапевтическое применение
US20080221023A1 (en) 2004-05-27 2008-09-11 Campina Nederland Holding Use of Protein Hydrolysates For the Manufacture of a Medicament For Prophylaxis and/or Treatment of a Dpp-IV Mediated Condition
WO2006005757A2 (en) * 2004-07-12 2006-01-19 Dsm Ip Assets B.V. Blood pressure lowering oligopeptides
EP1831361B1 (de) 2004-12-23 2012-01-25 Campina Nederland Holding B.V. Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung
JP2009517464A (ja) * 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー．ブイ． グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用

Also Published As

Publication number Publication date
KR101331777B1 (ko) 2013-11-21
US20130096074A1 (en) 2013-04-18
JP5068174B2 (ja) 2012-11-07
US20090075904A1 (en) 2009-03-19
TWI421089B (zh) 2014-01-01
KR20070101253A (ko) 2007-10-16
WO2006068480A2 (en) 2006-06-29
WO2006068480A3 (en) 2007-01-04
EP1831361B1 (de) 2012-01-25
ES2381118T3 (es) 2012-05-23
DK1831361T3 (da) 2012-05-14
TW200621283A (en) 2006-07-01
US8273710B2 (en) 2012-09-25
JP2008525430A (ja) 2008-07-17
EP1831361A2 (de) 2007-09-12

Similar Documents

Publication Publication Date Title
ATE542896T1 (de) Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung
Lafarga et al. Bioactive protein hydrolysates in the functional food ingredient industry: Overcoming current challenges
Hatanaka et al. Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran
Tulipano et al. Characterisation of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: In silico and in vitro comparative studies
Liu et al. Functional peptides derived from rice bran proteins
Iwaniak et al. Peptides derived from foods as supportive diet components in the prevention of metabolic syndrome
WO1995025749A3 (en) Eating suppressant peptides
CY1111322T1 (el) Προϊοντα υδρολυσης πρωτεϊνων εμπλουτισμενα σε πεπτιδια που εχουν ενα καρβοξυ-τερματικο υπολειμμα προλινης
ATE297724T1 (de) Pharmakologische nahrungszusammensetzung zur nahrungsergängzung und nährwertverbesserung
Zhang et al. Comparison of dipeptidyl peptidase IV-inhibitory activity of peptides from bovine and caprine milk casein by in silico and in vitro analyses
WO2007004878A3 (en) Infant nutrition with hydrolised proteins
ATE366317T1 (de) Herstellung von peptiden und proteinen durch anhäufung in vom endoplasmatischen reticulum abgeleiteten proteinkörpern
WO2006000350A3 (en) Cosmetic compositions containing protein hydrolysates
BRPI0404497A (pt) Método para preparar um material de proteìna de soja solúvel e produto compreendendo um material de proteìna de soja solúvel
WO2010000801A3 (de) Molkenproteinhydrolysate enthaltend tryptophanhaltige peptide aus alpha-lactalbumin und deren verwendung
UA72915C2 (uk) Поживна ентеральна композиція, призначена для підтримки зростання та дозрівання недорозвинених шлунково-кишкових трактів у молодих ссавців та її застосування
Nongonierma et al. Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties
Zhang et al. Purification and identification of dipeptidyl peptidase IV and angiotensin-converting enzyme inhibitory peptides from silver carp (Hypophthalmichthys molitrix) muscle hydrolysate
TW200940080A (en) Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
Xie et al. In vitro-in silico screening strategy and mechanism of angiotensin I-converting enzyme inhibitory peptides from α-lactalbumin
ATE362372T1 (de) Verwendung von mindestens einem peptid des alpha- s2 caseins mit ace hemmender wirkung zur vorbereitung von arzneimitteln und nahrungsmitteln
Lydon et al. Nucleotide and primary amino acid sequence of porcine lactoferrin
WO2005002600A3 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
GB9917725D0 (en) Peptides
Dong-Min et al. Angiotensin-I converting enzyme inhibitory activity of enzymatic hydrolysates of mackerel muscle protein